Genta Incorporated is a biopharmaceutical company focused on the identification, development and commercialization of drugs for the treatment of people with cancer. Genta has built a broad portfolio of proprietary products in various stages of clinical development. The Company’s drugs include Ganite^® (gallium nitrate injection), tesetaxel, and oral gallium. Genta is committed to developing innovative products to better the lives of people with cancer.  Learn More